Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Joseph D. Keegan currently holds 15,411 shares of RESPONSE BIOMEDICAL CORP (RBM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Joseph D. Keegan has been a net seller of RBM stock. They have purchased $0 and sold $2.7M worth of shares.
Joseph D. Keegan's most recent insider trade was on Oct 30, 2025, when they sold 1,640 shares at $0.00 per share.
Joseph D. Keegan serves as Executive at RESPONSE BIOMEDICAL CORP (RBM). They have executed 79 insider transactions totaling $2.7M over their tenure at the company.
Joseph D. Keegan holds the position of Executive at RESPONSE BIOMEDICAL CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Joseph D. Keegan has shown a selling trading pattern, with $0 in total purchases and $2.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Joseph D. Keegan was on Mar 26, 2007, when they sold $2.1M worth of MDCC shares. This transaction involved 60,000 shares at $35.50 per share.
Joseph D. Keegan currently owns 15,411 shares of RESPONSE BIOMEDICAL CORP (RBM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Joseph D. Keegan's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Joseph D. Keegan has 79 Form 4 filings on record as an insider at RESPONSE BIOMEDICAL CORP.
Set alerts for Joseph D. Keegan and 40,000+ other insiders.